NewsBite

Benitec takes on deadly genes

James Eyers
James EyersSenior Reporter

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Benitec last week stitched up a research agreement with City of Hope, a leading cancer research and treatment centre in Los Angeles.

The Queensland-based biotech which has developed a proprietary technology known as "DNA-directed RNA interference", which targets DNA and attempts to "silence" the genes responsible for serious diseases will fund the initial research and potentially receive a revenue stream if a treatment is commercialised.

Loading...
James Eyers writes on banking, payments and fintech. He is a former legal and investment banking editor at the AFR, has degrees in commerce and law from UNSW, and is co-author of Buy now, pay later: The extraordinary story of Afterpay Connect with James on Twitter. Email James at jeyers@afr.com.au

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Latest In Politics

Fetching latest articles

Most Viewed In Politics

    Original URL: https://www.afr.com/politics/benitec-takes-on-deadly-genes-20040901-jlr5l